Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Adamas Pharma (ADMS) Lower on $50M Stock Offering
-
Adamas Pharmaceuticals (ADMS) PT Lowered to $5 at Cowen
-
Cowen Downgrades Adamas Pharmaceuticals (ADMS) to Market Perform
-
Adamas to Present at Two Upcoming Investor Conferences
-
Adamas Pharmaceuticals (ADMS) PT Lowered to $30 at Cowen
-
Adamas Pharmaceuticals (ADMS) PT Lowered to $35 at Cowen
-
Adamas to Present at Two Upcoming Investor Conferences
-
Adamas Pharmaceuticals (ADMS) Named Best 2018 Idea at Cowen; 'Meaningfully Undervalued'
-
Adamas Pharmaceuticals (ADMS) PT Raised to $55 at Cowen
-
Adamas Pharma (ADMS): Management Meeting And Consultants Reinforce August ADS-5102 Approval - Cowen
-
Adamas to Present at the 37th Annual Cowen Health Care Conference
-
Adamas Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
-
Streetinsider.com's Hot Lunchtime Reads 1/19: (CMG) (ADMS) (TSLA) (SUNE)
-
UPDATE: Cowen Starts Adamas Pharmaceuticals (ADMS) at Outperform
-
Adamas Pharma (ADMS) Prices 2.5M Shares at $23
-
Adamas Announces Pricing of Public Offering of Common Stock
-
Adamas Pharma (ADMS) Announces 2.5M Common Stock Offering
-
Adamas Announces Proposed Public Offering of Common Stock

